Category: San Jose BioCenter
Date: April 22, 2010
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. Attendees must apply and be approved to attend. To apply, please send your Executive Summary to Aurélie at aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: June 23, 2010
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $150 to $175
Through the “Meet with…” Series, we provide you with greater access to partnering and financing opportunities. In this session, members of Gilead will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Gilead team. Finally, each pre-approved attendee* will be granted a private meeting with a member of the Gilead team. *Attendees must apply and be approved to attend the one-on-one meetings. To apply, please send your Executive Summary to aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: March 2, 2010
Time: 12:00PM-2:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
The achievement of a cleared Investigational New Drug application (IND) is a critical milestone for most small to mid-sized companies. Senior Management teams face many challenges when working on these applications. These are not easy applications to create, and there are many potential pitfalls. During this presentation the pitfalls that CEOs and senior management teams need to be aware of will be identified. A panel session will follow the main presentation at which time the audience will be able to address questions to members of the panel. Webinar link-up is available for those who are not able to participate on-site. Please indicate if you would like to join by webinar when signing up. The details for the webinar will be sent to participants before the event. | Registration fee: from $0 to $40 | 12:00-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Speakers: Debra Gosling, Account Executive, Regulatory & Clinical Services, Liquent Inc. | Tom Delisi, Senior Consultant, Regulatory Services, Liquent Inc. | Kathryn Plank, Senior Regulatory Consultant, Liquent Inc. | Jim Hilferty, Operations Manager, Regulatory & Clinical Services, Liquent Inc.
Date: February 3, 2010
Time: 2:30PM-3:30PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: free
The Open House Tour is an opportunity for anyone interested in the BioCenter to tour the facility and the Core Labs, to meet the management, and learn more about the BioCenter history and its clients. The Tour starts at 2:30 and lasts around an hour depending on attendance and how curious you are! | Registration fee: free | 2:30-3:30 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Now, more than ever, start-ups can use all the help they can get. The San Jose BioCenter will provide your biotech or cleantech company with support for fundraising, business development, legal, lab support, HR and payroll activities, as well as, provide you with access to our $15 million dollar state-of-the-art laboratory facilities and shared equipment.
“In just 5 years San Jose BioCenter companies have raised over $1 Billion in deals and financing.” -Melinda Richter, Executive Director, San Jose BioCenter
Our mission is to provide life science and cleantech companies with the infrastructure, resources, networks and expertise they need to develop and commercialize their technology. The San Jose BioCenter was awarded the National Business Incubator Association (NBIA) International Incubator of the year award for 2009 because of our exceptional resources, programs and client success rate. After 1.5 years at the San Jose BioCenter, Tacere Pharmaceuticals inked a $145m development deal with Pfizer for its preclinical hepatitis C drug:
Date: March 3, 2010
Time: 2:30PM-3:30PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: free
The Open House Tour is an opportunity for anyone interested in the BioCenter to tour the facility and the Core Labs, to meet the management, and learn more about the BioCenter history and its clients. The Tour starts at 2:30 and lasts around an hour depending on attendance and how curious you are! | Registration fee: free | 2:30-3:30 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
More info and registration: http://www.acteva.com/booking.cfm?bevaid=194784
Date: February 2, 2010
Time: 11:30AM-2:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
The discovery and identification of a new molecular entity (NME) and the application of research required to show a proof-of-principle for a therapeutic agent can be rife with pitfalls and it is extremely difficult to qualify a new prospect for venture funding or partnering with another pharmaceutical company. This event will include discussions around: • Leveraging Drug Metabolism and Pharmacokinetics in Lead Selection and PreClinical Therapeutic Development • Moving From Research To Development: Avoiding The Pitfalls • Effective Partnering with a Contract Research Organization to Optimize Your Drug Development Plan • The Role of Preclinical Safety Assessment in the Drug Development Process. The session will conclude with a panel discussion to provide attendees with the opportunity for valuable exchanges with experts in the fields of drug development and regulatory toxicology. | Registration fee: from $0 to $40 | 11:30-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: January 21, 2010
Time: 1:00PM-3:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
You may have been a master of grant writing, but things are about to change! The NIH is unrolling a shortened and restructured format for grants starting in 2010. All applications for due dates on or after January 25, 2010 require use of new forms and new instructions. New instructions mean shorter page limits! The research plan is fully restructured and reflects new evaluation criteria. Even people who have written grants in the past are going to need to “relearn” the process. Join us for an interactive workshop on grant writing basics and pitfalls. This event will cover general submissions and writing strategies, with a special focus on NIH SBIRs new submission format, as well as other agencies, grants, and deadlines. | Registration fee: from $0 to $40 | 1:00-3:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: Tuesday, November 17, 2009
Time: 12:00PM-3:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $25
Join us for this “hands-on” workshop to examine the critical, financial due diligence necessary for companies approaching their first institutional round. In this intimate, “roll-up-your-sleeves” clinic, Dean (Kip) Witter and Craig Cytron from The Brenner Group will provide real-time guidance, to help you formulate credible due diligence that will stand up to the rigorous evaluation of a potential investor. Topics will include: Preparing accurate historical financial statements and Pro Forma forecasts; Generating Cap Tables and supporting documentation; Governance reporting; Operating plans and assumptions; in addition to other important criteria.
Date: Thursday, October 22, 2009
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $100 to $225
Emerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the “Meet with...” Series, we provide emerging companies with greater access to partnering and/or financing opportunities. In this session, Senior Managers from Genentech, Inc. will talk to potential licensees to first explain what they are looking for in a company. After the presentation, each attendee will be granted a private meeting with Anna Williamson or Peter Condon, both Senior Manager of Business Development at Genentech, Inc. Attendees must apply and be approved to attend. To apply, please send your Executive Summary to Aurélie by October 2nd at aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. You will be notified on October 9th if your application is accepted or rejected. | Application fee: free | Registration fee: from $100 to $225 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Speakers: Anna Williamson, Senior Manager, Business Development, Genentech Inc. | Peter Condon, Senior Manager, Business Development, Genentech Inc.
